| Melatonin as a potential antihypertensive treatment F Simko, L Paulis Journal of pineal research 42 (4), 319-322, 2007 | 281 | 2007 |
| Blood pressure modulation and cardiovascular protection by melatonin: potential mechanisms behind. L Paulis, F Šimko Physiological research 56 (6), 2007 | 266 | 2007 |
| Peripheral and central effects of melatonin on blood pressure regulation O Pechanova, L Paulis, F Simko International journal of molecular sciences 15 (10), 17920-17937, 2014 | 179 | 2014 |
| Novel therapeutic targets for hypertension L Paulis, T Unger Nature Reviews Cardiology 7 (8), 431, 2010 | 174 | 2010 |
| Therapeutic perspectives in hypertension: novel means for renin–angiotensin–aldosterone system modulation and emerging device-based approaches T Unger, L Paulis, DA Sica European heart journal 32 (22), 2739-2747, 2011 | 136 | 2011 |
| Angiotensin A/Alamandine/MrgD axis: another clue to understanding cardiovascular pathophysiology J Hrenak, L Paulis, F Simko International journal of molecular sciences 17 (7), 1098, 2016 | 119 | 2016 |
| Direct Angiotensin II Type 2 Receptor Stimulation in Nω-Nitro-l-Arginine-Methyl Ester–Induced Hypertension: The Effect on Pulse Wave Velocity and Aortic … L Paulis, STR Becker, K Lucht, K Schwengel, S Slavic, E Kaschina, ... Hypertension 59 (2), 485-492, 2012 | 116 | 2012 |
| The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension O Pechánová, J Zicha, L Paulis, W Zenebe, Z Dobesová, S Kojsová, ... European journal of pharmacology 561 (1-3), 129-136, 2007 | 113 | 2007 |
| AT2 receptor agonists: hypertension and beyond UM Steckelings, L Paulis, P Namsolleck, T Unger Current opinion in nephrology and hypertension 21 (2), 142-146, 2012 | 110 | 2012 |
| Regression of l-name–induced hypertension: The role of nitric oxide and endothelium-derived constricting factor L Paulis, J Zicha, J Kunes, S Hojna, M Behuliak, P Celec, S Kojsova, ... Hypertension Research 31 (4), 793-803, 2008 | 109 | 2008 |
| Elevated heart rate and nondipping heart rate as potential targets for melatonin: a review F Simko, T Baka, L Paulis, RJ Reiter Journal of pineal research 61 (2), 127-137, 2016 | 102 | 2016 |
| AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression P Namsolleck, F Boato, K Schwengel, L Paulis, KS Matho, N Geurts, ... Neurobiology of disease 51, 177-191, 2013 | 92 | 2013 |
| Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats F Simko, O Pechanova, V Pelouch, K Krajcirovicova, M Mullerova, ... Journal of Hypertension 27, S5-S10, 2009 | 89 | 2009 |
| Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome S Slavic, D Lauer, M Sommerfeld, UR Kemnitz, A Grzesiak, M Trappiel, ... Journal of molecular medicine 91, 811-823, 2013 | 86 | 2013 |
| Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure LA Danyel, P Schmerler, L Paulis, T Unger, UM Steckelings Integrated blood pressure control, 153-161, 2013 | 85 | 2013 |
| Brain renin–angiotensin system: does It exist? BS van Thiel, A Góes Martini, L Te Riet, D Severs, E Uijl, IM Garrelds, ... Hypertension 69 (6), 1136-1144, 2017 | 83 | 2017 |
| Experimental models of melatonin-deficient hypertension F Simko, RJ Reiter, O Pechanova, L Paulis Front Biosci 18, 616-625, 2013 | 83 | 2013 |
| Key advances in antihypertensive treatment L Paulis, UM Steckelings, T Unger Nature Reviews Cardiology 9 (5), 276-285, 2012 | 75 | 2012 |
| Melatonin and renal protection: novel perspectives from animal experiments and human studies J Hrenak, L Paulis, K Repova, S Aziriova, E J Nagtegaal, R J Reiter, ... Current pharmaceutical design 21 (7), 936-949, 2015 | 74 | 2015 |
| Cardiovascular effects of melatonin receptor agonists L Paulis, F Simko, M Laudon Expert opinion on investigational drugs 21 (11), 1661-1678, 2012 | 74 | 2012 |
